Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $123.7250 (2.74%) ($123.7250 - $123.7250) on Wed. Jul. 28, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.55% (three month average) | RSI | 43 | Latest Price | $123.7250(2.74%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.1% a day on average for past five trading days. | Weekly Trend | LGND declines -0.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(55%) IWC(53%) IWN(50%) | Factors Impacting LGND price | LGND will decline at least -1.275% in a week (0% probabilities). VIXM(-26%) UUP(-17%) VXX(-16%) UNG(-3%) TBT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.275% (StdDev 2.55%) | Hourly BBV | 2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $124.21 | 5 Day Moving Average | $122.08(1.35%) | 10 Day Moving Average | $120.8(2.42%) | 20 Day Moving Average | $124.21(-0.39%) | To recent high | -15.7% | To recent low | 9.5% | Market Cap | $1.988b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |